Kyrsten Sinema @SenatorSinema
Last year, we capped the cost of insulin for Medicare patients at $35/month. Now, Novo Nordisk is following our lead & reducing insulin prices by up to 75%. We'll keep delivering results so Arizonans can access the affordable health care they deserve. https://t.co/4CaCiHsn1X — PolitiTweet.org